Related by context. All words. (Click for frequent words.) 76 XL# anticancer compounds 76 Initiates Enrollment 76 Hsp# Inhibitor 76 R sorafenib tablets 76 Crofelemer budesonide foam 76 docetaxel emulsion 76 refractory chronic lymphocytic 76 AAG geldanamycin analog 75 candidates Azedra TM 75 Initiates Phase II 75 CYT# potent vascular disrupting 75 Pruvel TM 75 Announces Tentative Approval 75 cisplatin gemcitabine 75 TO AVOID PREGNANCY WHILE 75 Budesonide foam crofelemer 75 Telik logo TELINTRA 74 progressive metastatic prostate 74 Completes Patient Enrollment 74 pharmacogenomic translational research 74 pralatrexate injection folate analogue 74 ® bortezomib 74 Files IND 74 vinorelbine emulsion 74 R MSCRAMM 74 TRIOLEX HE# APOPTONE HE# 74 Submits IND 74 recurrent metastatic ovarian cancer 74 R lenalidomide 74 IMiDs ® compound 74 IMiDs ® 74 Xeloda ® 74 FUSILEV enhances 74 humanized therapeutic 74 Aeolus Pharmaceuticals Announces 74 ® lenalidomide 74 vinorelbine tartrate 74 Submits Response 74 sapacitabine CYC# 74 HCV RNA polymerase 73 Initiates Clinical Trial 73 hypoxia activated prodrug 73 palonosetron hydrochloride Injection Dacogen 73 Submits NDA 73 JAK2 Inhibitor 73 novel proprietary KL4 73 Receives Orphan Drug Designation 73 TRANSDUR ® 73 COPEGUS R 73 Submits Biologics License Application 73 Submits Supplemental 73 LymphoStat B TM 73 Alfacell proprietary ribonuclease 73 fusion enhancers 73 TM pralatrexate injection 73 Peginterferon alfa 2b 73 Mg Uk 73 Initiate Clinical Trial 73 ATRA IV 73 5 FU leucovorin 72 SPRYCEL ® 72 Therapeutic Competitors Companies 72 vapreotide acetate 72 Launches Generic Version 72 Reports Preclinical Data 72 Achieves Primary Endpoint 72 Vitrasert R 72 evaluating satraplatin 72 substantially excreted 72 accumulate preferentially 72 DP VPA 72 pan histone deacetylase 72 IMiDs R 72 Begins Dosing 72 pharmacokinetic equivalence 72 Granted Orphan Drug 72 HGS ETR1 mapatumumab 72 nilotinib Tasigna ® 72 Orally administered 72 kidney urologic 72 coronary stent merged 72 CYP#A# CYP#D# 72 DNA methyltransferase inhibitors 72 interferon beta 1a infertility 72 Evoltra ® 72 INSPIRE Trial Phase III 72 topical gel formulation 72 Pegloticase 72 Vidaza ® 72 proprietary intravenous formulation 72 successfully commercialize Iluvien 72 Demonstrates Significant 72 R Saizen R 72 novel VDA molecule 72 Receives Approvable Letter 72 CYP#A# isoenzyme 72 Meets Primary Endpoint 72 brand ciclesonide HFA 72 NS5b 72 Mg Usa 72 DIFICID ™ 72 markets COLAZAL 72 generation purine nucleoside 72 treat chronic sinusitis 71 Cardium Therapeutics TM 71 liposomal formulation 71 Kit CD# positive 71 Dementia Related Psychosis 71 plus prednisone prednisolone 71 evaluating picoplatin 71 developing Bicifadine serotonin 71 Initiates Clinical 71 Presents Preclinical Data 71 IMiDs 71 non nucleoside inhibitor 71 oncolytic virus therapies 71 Demonstrates Potential 71 acetonide FA 71 essential thrombocythemia ET 71 Anidulafungin 71 biologic antibody 71 Inc. www.micromet inc.com 71 Platinol ® cisplatin 71 Initiates Phase III 71 PI3K/Akt pathway inhibitor 71 Amgen Neulasta ® 71 Veronate R 71 Amgen Neulasta R 71 Demonstrates Sustained 71 MSCRAMM ® 71 radiation chemoradiation 71 NS5B polymerase 71 overactive bladder VANTAS R 71 dasatinib Sprycel ® 71 developing Zerenex ferric 71 Recurrent Glioblastoma 71 TRANSDUR ™ 71 panitumumab Vectibix R 71 Emtriva Viread 71 TRACON Pharmaceuticals 71 5 fluorouracil leucovorin 71 sorafenib tablets 71 Demonstrates Positive 71 FOLOTYN ® 71 Humanized Anti 71 IMPDH inhibitor 71 methylnaltrexone bromide 71 Presents Preclinical 71 plus fludarabine 71 demonstrated antitumor activity 71 XP# XP# 71 monoclonal antibody IgG1 Mab 71 vinorelbine injectable emulsion 71 Panzem R NCD 71 diagnostic molecular imaging 71 CysDisplay R 71 AKT inhibitor 71 intravesical infusion therapy 71 eye socket ruptured 71 Gets FDA Clearance 71 sarcoma melanoma 71 corticotropin injection 71 Pharma Merck Serono 71 Lenocta TM sodium stibogluconate 71 Teva Provides Update 70 Pruvel ™ 70 non porcine pancreatic 70 Navelbine R 70 liver resection surgeries 70 FDA APPROVES 70 Announces Poster Presentations 70 PRN FDA Approves 70 Oracea TM 70 5 lipoxygenase inhibitor 70 Ecallantide 70 MOVIPREP R 70 bevacizumab Avastin R 70 Vaccine Adjuvant 70 oral prodrug 70 Files Investigational 70 PROCTOCORT R Suppository Hydrocortisone 70 IgG1 monoclonal antibody 70 trastuzumab Herceptin R 70 developing ACAPODENE 70 FOLFOX6 chemotherapy regimen 70 triciribine phosphate monohydrate 70 Patients Treated With 70 Aztreonam Lysine 70 Receives Fast Track 70 CHEAP ONLINE PHARMACY LOW 70 MCSP respectively 70 liposome encapsulated 70 2 methoxyestradiol 70 CYP#A# substrate 70 Xcytrin R 70 Mylan Receives Approval 70 Earns Milestone Payment 70 cortisol synthesis 70 pharmacologically active isomer 70 oral picoplatin 70 Temsirolimus 70 synthetic peptide containing 70 XL# XL# 70 VANTAS ® 70 GVAX ® 70 Presents Positive 70 Aradigm Logo 70 endoscopic autofluorescence imaging 70 cladribine Cladribine Tablets 70 Levoleucovorin 70 dextromethorphan quinidine 70 prokinetic agent 70 Novel Oral 70 Gets Bearish Confirmation 70 BCG refractory carcinoma 70 oral nucleoside analogue 70 COLAZAL R 70 cosmetic cosmeceutical products 70 novel orally inhaled 70 FDA Accepts 70 Refractory Hodgkin Lymphoma 70 R famotidine 70 DOXIL R 70 commercialize CorMedix drug 70 please visit www.abraxane.com 70 Licenses Novel 70 interferon gamma 1b 70 gets USFDA nod 70 highly purified pasteurized 70 NEBIDO VANTAS SUPPRELIN LA 70 targeted anticancer biopharmaceuticals 70 Aloprim TM allopurinol sodium 70 SPL# Gel vaginal microbicide 70 rusalatide acetate 70 pentadentate logo R 70 adenosine injection 70 reduce serum phosphate 70 Combination REOLYSIN R 70 Hedgehog Pathway Inhibitor 70 MAGE A3 ASCI 70 AN# topical anti 70 TKB# 70 Fludara ® 70 novel topoisomerase 70 selective A2A adenosine receptor 70 product platforms AZX# 70 platform HDL Mimetic 70 By JAMAAL ABDUL 70 erlotinib Tarceva R 70 logo Oncotype Oncotype 70 include ClindaReach TM 70 Dyax logo 69 VEGFR2 inhibitor 69 Generx TM 69 Initiates Dosing 69 cyclophosphamide methotrexate 69 Receives Orphan Drug 69 rxRNA 69 Thalomid ® 69 vinca alkaloid 69 including eniluracil ADH 69 Barr Receives Approval 69 LymphoStat B belimumab 69 Ph + acute lymphoblastic 69 please visit http:/www.sunesis.com 69 certain protein tyrosine 69 Retisert R 69 erlotinib Tarceva ® 69 HCl PEPCID ® famotidine 69 Selzentry Celsentri 69 Personalized Immunotherapy 69 markets HP Acthar 69 targeted antifolate 69 Prodarsan R 69 microtubule inhibitor 69 novel histone deacetylase 69 Bayer HealthCare Onyx Pharmaceuticals 69 sodium sulfate sodium chloride 69 TELINTRA 69 METOZOLV TM ODT metoclopramide 69 relapsed MM 69 hoFH 69 tumor activated prodrug 69 IN PATIENTS WITH 69 5 HT3 antagonist 69 IG HCR ;) CO 69 proprietary polysaccharide 69 topically applied SEPA 69 Pain Neutralizer holds 69 Initiates Clinical Trials 69 MEK Inhibitor 69 Multiple Ascending Dose 69 class anticancer quinolone 69 Irinotecan 69 Receives Tentative Approval 69 alpha interferons 69 ergot derivatives 69 PrevOnco 69 induced macular edema 69 Tarceva TM 69 Zorbtive TM 69 Genentech sanofi aventis 69 IAP inhibitor 69 oral immunomodulatory 69 TM Aganocide 69 Staphylococcus aureus Immune Globulin 69 Receives Milestone Payment 69 semi synthetic lipoglycopeptide 69 visit www.genenews.com 69 apoptosis inducer 69 personalized cellular immunotherapy 69 Shows Promise Against 69 PROVENGE ® 69 Wafer polifeprosan 69 subsidiaries visit http:/www.apricusbio.com 69 manufactures minimally invasive 69 Announce Merger Agreement 69 FUSILEV ® 69 Darinaparsin 69 TSX Delisting Review 69 Panzem NCD 69 cytidine nucleoside analog 69 MTP inhibitor 69 DNA demethylating agent 69 please visit www.middlebrookpharma.com 69 Zolpimist ™ 69 Trastuzumab DM1 69 ONCASPAR 69 ZOLINZA 69 MKC# MT 69 Opterone R 69 pipeline ImmunoGen collaborators 69 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 69 inhibit platelet function 69 BioSante Pharmaceuticals Announces 69 lead molecular radiotherapeutic 69 mertansine 69 Drug Candidate 69 oxacillin penicillin 69 chimeric monoclonal antibody 69 inflammatory PDE 69 PDX pralatrexate 69 Predictive medicine 69 omeprazole widely 69 mitoxantrone plus 69 Immunotherapeutic 69 please visit http:/www.vandapharma.com 69 Initiates Phase 2b 69 R ferumoxytol Injection 69 oropharyngeal candidiasis OPC 69 Numoisyn R 69 potently inhibit 69 proprietary radiolabeled monoclonal 69 orally administered inhibitor 69 FEMALES SHOULD BE ADVISED 69 Orally Active 69 Navelbine ® 69 Granulocyte Colony Stimulating Factor 69 Phase 2b Clinical Trial 69 AzaSite ISV 69 Vinorelbine 69 Selective Electrochemical Tumor Ablation 69 tenofovir disoproxil fumarate Viread 69 Pivotal Phase III 69 Completes Enrollment 69 PEGylated anti 69 PROCTOCORT ® Suppository Hydrocortisone 69 BUPHENYL R 69 Enterobacter spp 69 ® decitabine 69 Prolongs Survival 69 agonistic human 69 RAS MAPK pathway 69 tumor angiogenesis inhibitors 69 VISICOL R 69 hypereosinophilic syndrome 69 dyslipidemia hypertension diabetes 69 Antitumor Activity 69 PrevOnco ™ 69 ELADUR TM 69 attach auristatin 69 Acetate Rectal Suppositories 68 included exfoliative dermatitis 68 arsenic trioxide injection 68 paclitaxel Taxol ® 68 targeted radiotherapeutic 68 humanised monoclonal antibody 68 cetuximab Erbitux R 68 M# rationally 68 docetaxel Taxotere ® 68 evaluating tivozanib 68 Vidaza R 68 commercializing oxidized glutathione 68 Suppository Hydrocortisone Acetate Rectal 68 5 HT2A serotonin 68 toenail onychomycosis 68 peptidic compound 68 candidate deforolimus 68 ADP receptor antagonist 68 docetaxel Taxotere R 68 Acute Intermittent Porphyria 68 developing Surfactant Replacement 68 Kosan proprietary 68 Recombinant Human 68 Marfrig BMF & 68 estrogen receptor beta agonist 68 aplastic anemia AA 68 proprietary intranasal insulin 68 ELADUR ™ 68 Trobalt 68 Intermezzo ® zolpidem tartrate 68 Paris IPN Euronext 68 lintuzumab SGN 68 TNF Tumor Necrosis Factor 68 herpetic keratitis 68 Epirubicin 68 alfa 2a 68 Camptosar ® 68 Pruvel ™ prulifloxacin 68 Protease Inhibitor 68 delivers fluocinolone acetonide FA 68 inhibitor PPI 68 Empatic ™ 68 Zalypsis 68 Hormone Refractory Prostate Cancer 68 gemcitabine cisplatin 68 tests miRview TM 68 dependent kinase inhibitor 68 candidate TNFerade biologic 68 USP Tablets PEPCID 68 vaginal candidiasis 68 Temodar ® 68 telomerase inhibitor drug 68 Albuferon TM 68 ™ pralatrexate injection 68 Adjuvant Treatment 68 Cytogen marketed 68 HuMax TAC 68 Fast Track Status 68 myelodysplastic myeloproliferative diseases 68 folate analogue metabolic 68 antimitotic 68 NeuroSTAT ® 68 HCV polymerase 68 Pharmacokinetics PK 68 nasal calcitonin product 68 Known hypersensitivity 68 P#X# antagonist 68 Provectus Pharmaceuticals specializes 68 mesylate tablets approved 68 include Healive TM 68 acyclovir Lauriad R 68 nasal decolonization 68 Commences Phase 68 ODT metoclopramide HCl PEPCID 68 oral ferric iron 68 XL# XL# XL# XL# 68 gastrointestinal stromal 68 MetroGel 68 Imatinib mesylate 68 WERE YOU SURPRISED 68 sumatriptan succinate injection 68 Potelligent Technology 68 IONSYS TM 68 histamine dihydrochloride 68 HP Acthar Gel repository 68 PEGylated interferon 68 3TC lamivudine 68 CD# CEA 68 bendamustine ifosfamide 68 Maribavir 68 Atripla combines 68 approved incretin mimetic 68 Oral Calcitonin 68 Receives Complete Response 68 Luveris R Ovidrel R 68 superparamagnetic iron oxide nanoparticles 68 taxane derivative 68 EARNINGS HINDSIGHT #.# 68 NewsBite Downgrade Puts Pressure 68 developing KL4 surfactant 68 MSCRAMM R 68 COLAZAL ® 68 FDA Okays 68 memantine HCl 68 histone deacetylase HDAC inhibitor 68 5 HT2A inverse 68 Statin medicines sold 68 Targretin capsules 68 Genotyping Test 68 Exelixis compounds 68 Nventa proprietary CoVal 68 abnormal p# 68 * Azixa 68 Vitrasert ® 68 SinuNase ™ 68 LungAlert TM 68 pain palliation 68 By Lisa Eckelbecker 68 Phase 2a Trial 68 ARRY # 68 Procardia XL 68 inhibits dihydrofolate reductase 68 biologic DMARD 68 Progenta TM 68 human C1 inhibitor 68 castration resistant hormone refractory 68 Aurora Kinase 68 carmustine 68 Through Glycoscience R 68 Grants Orphan Drug 68 PEGylated docetaxel 68 Panflu TM Sinovac 68 sulfonylurea glimepiride 68 Corp. AMEX CVM 68 CDK cyclin dependent 68 Ceragenin ™ 68 TELINTRA R 68 Novartis Trileptal 68 Alkeran 68 lexidronam injection 68 syndrome overactive bladder 68 TRIOLEX ™ 68 PRICE GREAT DISCOUNT FREE 68 cisplatin carboplatin 68 Marqibo TM 68 investigational oral inhibitor 68 oxandrolone USP 68 Annamycin 68 Company perfluorocarbon PFC 68 Complicated Skin 68 Posaconazole 68 lipoglycopeptide 68 Voreloxin 68 THAT ALLOWS 68 Company Nasdaq RGDX 68 STRIKE PRICE COMPARES TO 68 treats acute lymphoblastic 68 Receive Milestone Payment 68 Randomized Phase II 68 topical non steroidal 68 Captisol ® 68 Panzem R 68 OvaRex R 68 HuMax 68 thrombin component 68 Tesmilifene 68 peptibody 68 4SC AG ISIN DE# 68 Shellgel TM injectable viscoelastic 68 Bosutinib 68 candidate REP# 68 COPEGUS therapy 68 Ribavirin causes 68 TURNING INSIGHTS INTO HOPE 68 MKC# MKC# PP 68 rapamycin derivatives 68 Cream Hydrocortisone Cream USP 68 2hours #mins #.#secs M 68 particularly SANCTURA XR 68 Retisert ® 68 oral talactoferrin 68 include ColorectAlert TM 68 Plaque Psoriasis 68 Solzira TM 68 Gemzar ® 68 personalized dendritic 68 International SMI SYNN 67 Warfarin Coumadin 67 itraconazole Sporanox 67 basal cell carcinoma squamous 67 Copegus ® 67 Fc fusion protein 67 Paraplatin ® 67 METOZOLV ™ ODT metoclopramide 67 Benzinga Volume Movers 67 Matt Kenseth Truex 67 cutaneous T 67 Romidepsin 67 include Alferon N 67 Viagra Soft Cialis Soft 67 tumor vascular disrupting 67 Serostim ® 67 Liprotamase 67 Therapeutic Competitors companiesandmarkets.com adEgemonye 67 prednisone prednisolone plus 67 non nucleoside HCV 67 alpha folate receptor 67 ADVANCE ILLUMINATE 67 Unanimously Recommends Approval 67 based pretargeting methods 67 2 inhibitor CYT# 67 Successfully Completes Phase 67 MKC# 67 PROCTOCORT R 67 Receives CE Marking 67 small molecule tyrosine 67 Regains NASDAQ 67 Presents Positive Preclinical 67 Tß4 67 active AKT inhibitor 67 Irinotecan Hydrochloride Injection 67 ALVESCO ® 67 AVI antisense 67 ® chorionic gonadotropin 67 ALTROPANE R 67 receptor tyrosine kinase inhibitor 67 Soft Tissue Sarcoma 67 novel antimitotic agent 67 sunitinib Sutent 67 aerosolized AAT 67 ALN HPN 67 Gonal f R follitropin 67 recombinant interferon 67 develop HBV reactivation 67 HepaGam B 67 Zenvia ™ 67 Doxycycline Tablets 67 Improved Progression 67 hyperphenylalaninemia HPA due 67 Shows Statistically Significant 67 Vytorin combines 67 Resurgex Plus R 67 fluoropyrimidine 67 Sapacitabine 67 Altera Nebulizer System 67 EGFr expressing metastatic colorectal 67 small molecule thrombopoietin 67 5q MDS 67 molecular therapeutics immunotherapies 67 Traci Arbios 67 IMPACS R 67 orally disintegrating 67 metastatic HER2 negative 67 R bisoprolol Euthyrox 67 Intravenous Human 67 Xanafide 67 metaglidasen 67 palonosetron hydrochloride injection 67 Gemzar gemcitabine 67 lymphoma multiple myeloma 67 chemotherapeutic agents carboplatin 67 #mg/#mg 67 EXCHANGE OR 67 Adenoscan R 67 Phase 2b Trial 67 ® adefovir dipivoxil 67 infection epistaxis dyspnea exfoliative 67 Investigational Oral 67 please visit http:/www.avastin.com 67 catheter occlusion 67 migraine headaches neuropathic pain 67 Nabi HB Intravenous 67 EHT AGN 67 Methylnaltrexone 67 Oral Suspension USP 67 Announce Licensing Agreement 67 programs visit http:/www.bionovo.com 67 www.introgen.com 67 epoetin zeta 67 technology visit http:/www.genmab.com 67 estramustine 67 FOR FURTHER INFORMATION ABOUT 67 polyneuropathy HIV DSP 67 ONYX PHARMACEUTICALS 67 WHILE THE COMPANY 67 Phase #b/#a clinical 67 Salix Pharmaceuticals Announces 67 TIME TO TEACH 67 virus HCV protease inhibitor 67 TRISENOX ® 67 penicillin VK 67 including cyclosporine methotrexate 67 r hGH 67 Kinase Inhibitor 67 R rilonacept Injection 67 novel oral anticoagulant 67 intranasal formulation 67 induced mucositis 67 Spectrum Pharmaceuticals Announces 67 Plavix clopidogrel bisulfate 67 Viread tenofovir disoproxil fumarate 67 BRILINTA 67 introduced NEUGENE 67 LAST QUARTER ANNUALIZED SALES 67 HARD ENOUGH WITH 67 selective modulator 67 aluminosilicate clay 67 Enrolls First 67 Angiotensin Converting Enzyme 67 selective kinase inhibitor 67 DepoCyt ® Abelcet ® 67 proprietary Capillary Aerosolization Technology 67 Numoisyn ® Lozenges 67 Adenoviral 67 GRNOPC1 contains 67 pediatric Crohn disease 67 Anti Tumor 67 therapeutically inactive prodrug 67 potassium chloride sodium ascorbate 67 Zemiva TM 67 antiangiogenesis therapies 67 Peginterferon 67 opioid mediated 67 R Bortezomib 67 histone deacetylase inhibitor 67 Omacetaxine 67 both intercalates DNA 67 SinuNase TM 67 Cytarabine 67 CCR9 antagonist 67 lung pancreatic 67 HAS WRITTEN 67 Divigel R 67 Elotuzumab 67 albiglutide 67 Shigatoxin producing E. coli 67 gemifloxacin mesylate tablets fluoroquinolone 67 alvespimycin 67 Ovitrelle R Serostim 67 ADVERSE EVENTS 67 EGFr expressing mCRC 67 ZANAFLEX CAPSULES ® tizanidine 67 YONDELIS 67 WEALTH MINERALS LTD 67 please visit www.cpexpharm.com 67 topoisomerase II inhibitor 67 barbiturates benzodiazepines 67 oral chemotherapeutic agent 67 oral beclomethasone dipropionate 67 6 sulfatase 67 candidate XP# 67 Announces FDA Clearance 67 mequinol 67 Pebble Beach Calf 67 thalidomide Thalomid 67 peripherally acting 67 Nasulin ™ 67 small molecule chemotherapeutic 67 Lenalidomide 67 DG# compounds targeting 67 Saltalamacchia Vazquez 67 papillary renal cell carcinoma 67 HCV NS5B polymerase 67 ceftazidime 67 potent suppressor 67 potentially hepatotoxic 67 patients coinfected 67 Pazopanib 67 BY CHRIS REDFORD 67 Archexin 67 amoxicillin penicillin 67 GW# [003] 67 cromolyn sodium 67 By MANON L. 67 By JENNIFER LEARN 67 Nipent R 67 metastatic neuroendocrine tumors 67 hypertrichosis occurred 67 markets Testim ® 67 Phase IIa Clinical Trial 67 myelofibrosis polycythemia vera 67 systemic anaplastic large 67 refractory NSCLC 67 developing ostarine selective 67 vi Immtech ability 67 please visit www.medicinova.com 67 DexaSite 67 Announce License Agreement 67 Dabigatran etexilate 67 orally inhaled 67 neutropenia dehydration dyspnea 67 5 Fluorouracil 67 Perforomist TM formoterol fumarate 67 Paraplatin 67 Pentad TM 67 Bearish Average Crossover 67 sNDAs 67 Improves Survival 67 plus dacarbazine 67 visit www.sciclone.com 67 CIP TRAMADOL ER 67 metastatic colorectal carcinoma 67 thetreatment 67 interferon alpha IFN 67 NDA Submission 67 anti miRs antisense oligonucleotide 67 Unigene nasal calcitonin 67 CoTherix logo 67 Myriad logo BRACAnalysis 67 candidate Zemiva TM 67 LES EXPLOSIFS NORDEX LTEE 67 Jermaine Jenas Tottenham 67 receiving XGEVA 67 Tibotec Therapeutics division 67 NATIONAL ECONOMIC COUNCIL DIRECTOR 67 Trial Evaluating 67 Zidovudine Tablets 67 Adjunctive Therapy 67 combines bupropion 67 Transdermal Patch 67 nucleoside analog 67 include Altastaph TM 67 sapropterin dihydrochloride 67 Myocet 67 brivanib 67 Systemic Delivery 67 website www.novavax.com 67 anthracycline derivative 67 paclitaxel poliglumex 67 Albuferon albinterferon alfa 2b 67 hormone LHRH antagonist 67 BUPHENYL 67 1hour #mins #.#secs M 67 Romiplostim 67 HepeX B TM 67 Silodosin 67 foods insect stings 67 LEP ETU 67 Proellex TM 67 Company website www.anormed.com 67 Proc Am Soc 67 MyVax R 67 Quatrotec offices 67 orally bioavailable mimics 67 visit www.targanta.com 67 Hydrochlorothiazide Tablets 67 recombinant biopharmaceutical 67 topical anti infectives 67 mesylate 67 potent triglyceride lowering 67 BEMA ® 67 Arno Therapeutics 67 Initiates Phase 67 oral proteasome inhibitor 67 Maxy G# 67 SYCREST 67 UCB Keppra 67 Severe hypersensitivity reactions 67 Transdrug R 67 HDAC Inhibitor 67 By Priyanka Dayal 67 diagnostic radiopharmaceutical 67 novel synthetic PEGylated 67 nano particle tumor suppressor 67 R bortezomib 67 FDA Approves Novel 67 Vitamin D analogue 67 anthracycline taxane 67 PNP inhibitor 67 monoclonal antibody conjugated 67 Genentech Wyeth Pharmaceuticals 67 irinotecan doxorubicin oxaliplatin paclitaxel 67 visit www.genmab.com 67 gastrointestinal disorders ATI 67 Pruvel 67 anionic backbone 67 Inc. NASDAQ VSGN 67 rash pruritus nausea 67 ThermoDox R 67 Tyrosine Kinase Inhibitor 67 investigational immunotherapy 67 Taxotere docetaxel 67 dimebon latrepirdine 67 please visit http:/www.supergen.com 67 Cloretazine 67 HuCAL GOLD R 67 AcryMed technologies 67 MEDAREX 66 PEGylated irinotecan 66 CAUTIONARY STATEMENT UNDER 66 Present Preclinical Data 66 Fast Track designations 66 Campto 66 Anthracycline 66 var arrContent = 66 NOTE POSIDUR ™ 66 inhibit oxidative stress 66 metastatic malignant 66 Angiox ® 66 Expanded Indication 66 lenalidomide Revlimid R 66 Lubiprostone 66 sulfonylhydrazine class 66 visit www.solitaireminerals.com 66 HepeX B 66 NeutroPhase TM 66 HuCAL PLATINUM ® CysDisplay 66 treat hyperproliferative disorders 66 Begin Clinical Trials 66 Phase IIb Clinical Trial 66 Other ImmunoGen collaborative 66 CD4 monoclonal antibody 66 neuro inflammatory disorders 66 Glufosfamide 66 mitogen activated ERK kinase 66 Adnectin 66 Eraxis 66 TO TREAT 66 infectious diseases autoimmune diseases 66 Ganciclovir 66 indinavir Crixivan 66 Epothilone D 66 Advanced Melanoma 66 THAT ARE DIFFICULT TO 66 PEG irinotecan 66 beta 1a 66 Peyronie disease Frozen Shoulder 66 volociximab 66 pancreatic enzyme replacement 66 Fondaparinux 66 AVAX AC Vaccine 66 investigational integrase inhibitor 66 R DepoCyt 66 Horizant ™ 66 lamivudine zidovudine 66 treat male hypogonadism 66 denileukin diftitox 66 prostanoid 66 Inc. AMEX YMI 66 R sipuleucel T 66 SELLERS ABANDONING SHARES OF 66 lexidronam injection PROSTASCINT 66 novel DACH platinum 66 HepDirect prodrug 66 fludarabine phosphate 66 Clindamycin 66 Onyx Pharmaceuticals Announces 66 Includes KCI proprietary 66 alkylating agent 66 ciprofloxacin hydrochloride 66 Epigenomics proprietary 66 Elvitegravir 66 plasma kallikrein inhibitor 66 solid tumors ZYBRESTAT 66 Phase III Clinical Trial 66 Nasdaq XTLB 66 triggers apoptosis programmed 66 THE UNDERLYING FUTURE 66 Daclizumab 66 Namenda Memantine HCl 66 Vertex hepatitis C 66 selective estrogen receptor modulator 66 FULL IMPACT 66 IT HARD TO 66 AND TRY TO 66 CCR5 receptor antagonist 66 Solazed TM 66 CD# antibody [002] 66 novel tubulin binding 66 Gleevec resistant 66 MANAGEMENT 'S CURRENT BELIEFS 66 Copegus R 66 ThermoDox ® clinical 66 By Thomas Gryta 66 antibiotic amikacin 66 PATENT FOR 66 Navarrete replaces 66 products MKC# PP 66 Nexavar sorafenib tablets 66 var arrMeta = 66 Inc. ProMetic www.prometic.com 66 levoleucovorin 66 Gamunex C 66 KIDS FINANCIAL SKILLS 66 Azacitidine 66 hyaluronidase enzyme 66 SEA SEA 66 Pemetrexed 66 DO YOU NEED TO 66 polysaccharide polymer 66 Oral NKTR 66 G#DT 66 FDA Approves Generic 66 proprietary capillary aerosolization 66 Sodium oxybate 66 Canvaxin TM 66 serotonin norepinephrine reuptake inhibitor 66 % pramoxine HCl 66 BrachySil ™ 66 novel immunomodulatory 66 metabolic disorders Saizen R 66 PRESENTED AT 66 INTEGRILIN R eptifibatide Injection 66 taxane chemotherapy administered 66 mda 7 66 Quinamed R 66 Triapine 66 BrachySil TM 66 agents Tabun Sarin 66 Preclinical studies suggest 66 Besivance 66 aldehyde dehydrogenase ALDH2 deficiency 66 chronic eosinophilic leukemia 66 Edwards Lifesciences AG 66 AERx ® 66 CAPE FEAR COMMUNITY COLLEGE 66 GTC recombinant form 66 AVASTIN